In recent years, AKR1C3 has been implicated in the progression of prostate cancer, breast cancer, colon cancer and oropharyngeal squamous cell carcinoma, and contributes to therapeutic resistance in these types of cancers [13,14,15]. The gene discussed is AKR1C3; the disease is breast cancer.